OSE Immunotherapeutics SA (OSE.PA)

EUR 7.17

(-1.38%)

Total Liabilities Summary of OSE Immunotherapeutics SA

  • OSE Immunotherapeutics SA's latest annual total liabilities in 2023 was 59.07 Million EUR , down -0.07% from previous year.
  • OSE Immunotherapeutics SA's latest quarterly total liabilities in 2024 Q2 was 59.47 Million EUR , down 0.0% from previous quarter.
  • OSE Immunotherapeutics SA reported annual total liabilities of 59.12 Million EUR in 2022, up 9.52% from previous year.
  • OSE Immunotherapeutics SA reported annual total liabilities of 53.98 Million EUR in 2021, up 51.61% from previous year.
  • OSE Immunotherapeutics SA reported quarterly total liabilities of 59.07 Million EUR for 2023 FY, down -0.07% from previous quarter.
  • OSE Immunotherapeutics SA reported quarterly total liabilities of 57.86 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of OSE Immunotherapeutics SA (2023 - 2012)

Historical Annual Total Liabilities of OSE Immunotherapeutics SA (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 59.07 Million EUR -0.07%
2022 59.12 Million EUR 9.52%
2021 53.98 Million EUR 51.61%
2020 35.6 Million EUR 17.15%
2019 30.39 Million EUR 100.65%
2018 15.14 Million EUR -30.85%
2017 21.9 Million EUR -12.45%
2016 25.02 Million EUR 893.33%
2015 2.51 Million EUR -9.49%
2014 2.78 Million EUR 131.92%
2013 1.2 Million EUR 31.15%
2012 915 Thousand EUR 0.0%

Peer Total Liabilities Comparison of OSE Immunotherapeutics SA

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -754.731%
ABIVAX Société Anonyme 131.05 Million EUR 54.919%
Adocia SA 31.87 Million EUR -85.375%
Aelis Farma SA 13.08 Million EUR -351.674%
Biophytis S.A. 15.84 Million EUR -272.762%
Advicenne S.A. 24.37 Million EUR -142.355%
genOway Société anonyme 14.45 Million EUR -308.582%
IntegraGen SA 5.97 Million EUR -887.977%
Medesis Pharma S.A. 6.42 Million EUR -819.348%
Neovacs S.A. 3.71 Million EUR -1491.515%
NFL Biosciences SA 3.62 Million EUR -1531.709%
Plant Advanced Technologies SA 6.78 Million EUR -771.07%
Quantum Genomics Société Anonyme 3.31 Million EUR -1684.806%
Sensorion SA 13.22 Million EUR -346.645%
Theranexus Société Anonyme 5.01 Million EUR -1077.767%
TME Pharma N.V. 2.78 Million EUR -2021.329%
Valbiotis SA 13.7 Million EUR -330.982%
TheraVet SA 1.48 Million EUR -3878.403%
Valerio Therapeutics Société anonyme 20.46 Million EUR -188.641%
argenx SE 402.79 Million EUR 85.333%
BioSenic S.A. 32.26 Million EUR -83.111%
Celyad Oncology SA 9.97 Million EUR -492.093%
DBV Technologies S.A. 38.74 Million USD -52.48%
Galapagos NV 1.56 Billion EUR 96.217%
Genfit S.A. 105.92 Million EUR 44.224%
GeNeuro SA 20.13 Million EUR -193.343%
Hyloris Pharmaceuticals SA 8.61 Million EUR -586.008%
Innate Pharma S.A. 132.29 Million EUR 55.342%
Inventiva S.A. 101.59 Million EUR 41.847%
MaaT Pharma SA 22.46 Million EUR -162.982%
MedinCell S.A. 77.77 Million EUR 24.034%
Nanobiotix S.A. 95.74 Million EUR 38.292%
Onward Medical N.V. 25.69 Million EUR -129.897%
Oryzon Genomics S.A. 25.12 Million EUR -135.136%
Oxurion NV 19.73 Million EUR -199.346%
Pharming Group N.V. 228.28 Million EUR 74.121%
Poxel S.A. 53.9 Million EUR -9.607%
GenSight Biologics S.A. 34.72 Million EUR -70.124%
Transgene SA 26.51 Million EUR -122.797%
Financière de Tubize SA 123.65 Million EUR 52.221%
UCB SA 6.56 Billion EUR 99.1%
Valneva SE 341.14 Million EUR 82.682%
Vivoryon Therapeutics N.V. 4.54 Million EUR -1199.296%